Select language:  
1800 620 420
Close menu

Research in Focus

Your support is so important

Sadly, blood cancer is one of the most common, costly and fatal cancers in Australia. There are currently no screening programs and there’s no way to prevent blood cancer.

While these numbers tell a staggering tale, it’s the real-life nightmare faced by families every day that means we cannot, and will not, rest.

Deanne lost her 13-year-old son Jacob to blood cancer and recalls the way he shared with his three siblings the news that there were no treatment options left.

“Jacob’s the youngest and he sat them all down, put his arms around them said, ‘my leukaemia’s back and I’m going to die. But it’s okay, we’re not going to stop fighting’.”

“I miss him every day and am dedicated to making sure he is never forgotten. This is the greatest fear for every parent who has lost a child. He will always be my ‘almost’ 14-year old, and not a day goes by that I don’t think about my cheeky and mischievous boy watching over us.”

(Pictured) The McLeod-Steinmetz family. From left, Jon, Jonathon, Jacinta, Jacob, Deanne and Ryan.

Your donations in action

Your generosity is working hard to drive better outcomes for Australians with blood cancer.

Investing in the researchers of tomorrow, today

Funding our country’s early career researchers will bring tomorrow’s breakthroughs sooner.

Excitingly, two of Australia’s promising researchers have been awarded Leukaemia Foundation and Haematology Society of Australia and New Zealand (HSANZ) PhD scholarships this year.

Thanks to the generosity of wonderful supporters like you, the research of Basit Salik and Dr Julian Grabek is working to improve the understanding and treatment for types of blood cancer called acute myeloid leukaemia (AML) and myeloproliferative neoplasms (MPN).

Their focus on the biology of blood cancer means your support is fuelling high-impact and innovative research – research that may help change the way some blood cancers are diagnosed and treated.

“I’m so grateful for your support. It’s powerful to think that together, supporter and researcher, we can work to improve outcomes for Australians with MPN.”
– Dr Julian Grabek

Basit Salik – Research Scientist, QIMR Berghofer. Basit’s research is investigating the biology of AML cells that allows them to adapt and survive current treatments, in order to develop new therapies. We thank Brydens Lawyers for their kind support of this PhD scholarship.
Dr Julian Grabek – Clinician Researcher, QIMR Berghofer. His research aims to identify early stages of acute leukaemia transformation in MPN, so that new treatments can be developed. We thank the Bourne Foundation for their kind support of this PhD scholarship.

“I’m so grateful for your support. It’s powerful to think that together, supporter and researcher, we can work to improve outcomes for Australians with MPN.”
– Dr Julian Grabek


Last updated on February 15th, 2022

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.